How is obesity defined?
A chronic, progressive, relapsing, multifactorial, neurobehavioral disease in which excess body fat causes adipose tissue dysfunction and abnormal physical forces, leading to adverse metabolic, biomechanical, and psychosocial health consequences.
What are the key diagnostic criteria for obesity?
What is adiposopathy?
Dysfunction of adipose tissue endocrine and immune function leading to metabolic disease (“sick fat disease”).
What is fat mass disease?
Physical stress or damage caused by excessive fat mass on other body tissues.
Are the health effects of obesity just co-morbidities or risk factors?
No — they are direct adverse consequences of excess body fat.
How is BMI calculated?
BMI = weight (kg) ÷ height (m²)
What are advantages of using BMI?
What are disadvantages of using BMI?
What key aspects should be covered in the history of an obese patient?
What should be assessed on physical examination?
What defines a very low-calorie diet (VLCD)?
Less than 800 kcal/day, using formulated meal replacements under medical supervision.
How do VLCDs compare to standard low-calorie diets?
Cause more rapid weight loss due to lower energy intake.
What metabolic improvements can VLCDs produce?
What are risks of VLCDs?
Fatigue, nausea, constipation, diarrhoea, cold intolerance, increased gallstones, and possible weight regain.
What must be assessed before starting an exercise program?
What are the 5 A’s of obesity management?
What class of medication is Orlistat?
Gastrointestinal lipase inhibitor.
What is Orlistat’s mechanism of action?
Impairs gastrointestinal fat absorption.
What are potential adverse effects of Orlistat?
What class of drug is Liraglutide?
GLP-1 (glucagon-like peptide-1) receptor agonist.
How is Liraglutide administered?
Subcutaneous injection via prefilled multi-dose pen.
What is the recommended maintenance dose of Liraglutide for obesity?
3 mg daily, at any time of day, regardless of meals.
What is the Liraglutide dose escalation schedule?
When should bariatric surgery be considered?
In potential candidates with severe obesity, after multidisciplinary assessment and failure of conservative therapy (specific criteria not provided in notes).